Boothbay Fund Management’s Astria Therapeutics ATXS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-25,453
| Closed | -$358K | – | 1346 |
|
|
2024
Q1 | $358K | Sell |
25,453
-36,490
| -59% | -$514K | 0.01% | 986 |
|
|
2023
Q4 | $476K | Hold |
61,943
| – | – | 0.01% | 860 |
|
|
2023
Q3 | $462K | Sell |
61,943
-26,716
| -30% | -$199K | 0.01% | 886 |
|
|
2023
Q2 | $739K | Sell |
88,659
-51,964
| -37% | -$433K | 0.02% | 787 |
|
|
2023
Q1 | $1.87M | Buy |
140,623
+33,801
| +32% | +$450K | 0.04% | 579 |
|
|
2022
Q4 | $1.59M | Buy |
106,822
+5,203
| +5% | +$77.5K | 0.04% | 568 |
|
|
2022
Q3 | $919K | Buy |
101,619
+25,846
| +34% | +$234K | 0.02% | 810 |
|
|
2022
Q2 | $227K | Buy |
+75,773
| New | +$227K | 0.01% | 1413 |
|
|
2021
Q3 | – | Sell |
-14,000
| Closed | -$177K | – | 1651 |
|
|
2021
Q2 | $177K | Sell |
14,000
-1,899
| -12% | -$24K | 0.01% | 1395 |
|
|
2021
Q1 | $276K | Buy |
15,899
+4,388
| +38% | +$76.2K | 0.01% | 1013 |
|
|
2020
Q4 | $148K | Buy |
+11,511
| New | +$148K | 0.01% | 967 |
|
|
2018
Q4 | – | Sell |
-380
| Closed | -$18K | – | 578 |
|
|
2018
Q3 | $18K | Buy |
+380
| New | +$18K | ﹤0.01% | 636 |
|